Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
14 Ergebnisse
Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION
1. Field of the Invention
With an emphasis on women's overall health, the invention pertains to improved prevention and treating agents, and methods for preventing and treating, mammary cancer.
2. Description of Related Art
In addressing mammary (breast) cancer, it is
Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION
1. Field of the Invention
With an emphasis on women's overall health, the invention pertains to improved prevention and treating agents, and methods for preventing and treating, mammary cancer.
2. Description of Related Art
In addressing mammary (breast) cancer, it is
Anti-cancer tamoxifen-melatonin hybrid ligand
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION
1. Field of the Invention
Two previously known active agents are covalently linked into a particularly constructed hybrid ligand for preventing or treating cancer in animals or humans, particularly breast cancer in mammals.
2. Description of Related Art
Both tamoxifen and
Compositions and methods of effecting contraception utilizing melatonin
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
This invention relates to a method of inhibiting ovulation in human females. More particularly, the invention relates to a method of inhibiting ovulation by administering an ovulation-inhibiting amount of melatonin. Optionally, the melatonin is administered in combination with
Contraceptive and menstrual cycle controlling drug having oncostatic therapeutic properties for treatment of mammary tumors and melanomas, and method therefor
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION
The present invention relates to a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic preventive and therapeutic properties for treating mammary tumors and melanomas and a method therefor.
After several years of studies and experiments,
Derivatives of 2-aminopyridine as adenosine A.sub.2B receptor antagonists and ligands of the melatonin MT.sub.3 receptors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is filed under the provisions of 35 U.S.C. .sctn. 371 and claims the priority of International Patent Application No. PCT/EP2016/053509 filed on 19 Feb. 2016 entitled "DERIVATIVES OF 2-AMINOPYRIDINE AS ADENOSINE A.sub.2B RECEPTOR ANTAGONISTS
Melatonin-based treatment and diagnosis of bile duct disease
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the field of molecular biology, bile duct disease, and diagnosis. More particularly, it concerns methods for treatment of a subject by administration of a melatonin signaling modulator. The invention
Unifying mechanism and methods to prevent cancer and neurodegenerative diseases
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION
Cancer is a disease that begins with mutation of critical genes: oncogenes and tumor suppressor genes. Mutation of critical genes allows for a cancer cell to evolve and ultimately results in pathogenic replication (a loss of normal regulatory control leading to excessive
Photoreceptor system for melatonin regulation and phototherapy
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
The present invention generally relates to the fields of neurology, neuroscience, and endocrinology and to light systems, light meters, lamps, filters, transparent and translucent materials, and methods of treating a variety of mammalian disorders and, more particularly to a
Photoreceptor system for melatonin regulation and phototherapy
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION
The present invention generally relates to the fields of neurology, neuroscience, and endocrinology and to light systems, light meters, lamps, filters, transparent and translucent materials, and methods of treating a variety of mammalian disorders and, more particularly to a
Multi-ingredient pharmaceutical composition for use in cancer therapy
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a .sctn. 371 national stage entry of International Application No. PCT/EP2015/074092, filed Oct. 19, 2015, which claims priority to European Patent Application No. 14189304.0, filed Oct. 17, 2014, the entire contents of which is
In vivo assessment of toxicity and pharmacokinetics of methylglyoxal
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to the in vivo assessment of toxicity and pharmacokinetics of methylglyoxal and to the curative effect of the pharmaceutical composition on cancer.
2. Description of Related Art
As early as 1913, it was observed that
Screening method using the RZR receptor family
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The current invention concerns the use of a receptor from the RZR/ROR receptor family or of a functional fragment thereof in a test of a compound for anti-autoimmune, anti-arthritic, anti-tumor, melatonin-like and/or melatonin-antagonistic activity and the production of a receptor ligand complex
Screening method using the RZR receptor family
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The current invention concerns the use of a receptor from the RZR/ROR receptor family or of a functional fragment thereof in a test of a compound for anti-autoimmune, anti-arthritic, anti-tumor, melatonin-like and/or melatonin-antagonistic activity and the production of a receptor ligand complex
Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird
- Arbeitet in 55 Sprachen
- Von der Wissenschaft unterstützte Kräuterkuren
- Kräutererkennung durch Bild
- Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
- Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
- Suchen Sie nach Heilkräutern nach ihrer Wirkung
- Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden
Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen
